The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An 11C-(R)-PK11195 PET Study
Open accessAbstract
UNLABELLED: Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disease characterized by chronic, profound, disabling, and unexplained fatigue. Although it is hypothesized that brain inflammation is involved in the pathophysiology of CFS/ME, there is no direct evidence of neuroinflammation in patients with CFS/ME. Activation of microglia or astrocytes is related to neuroinflammation. (11)C-(R)-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinoline-carboxamide ((11)C-(R)-PK11195) is a ligand of PET for a translocator protein that is expressed by activated microglia or astrocytes. We used (11)C-(R)-PK11195 and PET to investigate the existence of neuroinflammation in CFS/ME patients. METHODS: Nine CFS/ME patients and 10 healthy controls underwent (11)C-(R)-PK11195 PET and completed questionnaires about fatigue, fatigue sensation, cognitive impairments, pain, and depression. To measure the density of translocator protein, nondisplaceable binding potential (BP(ND)) values were determined using linear graphical analysis with the cerebellum as a reference region. RESULTS: The BP(ND) values of (11)C-(R)-PK11195 in the cingulate cortex, hippocampus, amygdala, thalamus, midbrain, and pons were 45%-199% higher in CFS/ME patients than in healthy controls. In CFS/ME patients, the BP(ND) values of (11)C-(R)-PK11195 in the amygdala, thalamus, and midbrain positively correlated with cognitive impairment score, the BP(ND) values in the cingulate cortex and thalamus positively correlated with pain score, and the BP(ND) value in the hippocampus positively correlated with depression score. CONCLUSION: Neuroinflammation is present in widespread brain areas in CFS/ME patients and was associated with the severity of neuropsychologic symptoms. Evaluation of neuroinflammation in CFS/ME patients may be essential for understanding the core pathophysiology and for developing objective diagnostic criteria and effective medical treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
Maldjian, J. A., Laurienti, P. J., Kraft, R. A., & Burdette, J. H. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00169-1 · Cited by 5,085
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
Fukuda, K., Straus, S. E., Hickie, I., Sharpe, M. C., Dobbins, J. G., Komaroff, A., & and International Chronic Fatigue Syndrome Study Group. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-12-199412150-00009 · Cited by 4,969
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203 · cited 1×
“The amygdala receives direct projection from the thalamus, which monitors the sensory information and mediates the facilitation of attention (30).”
BackgroundIschemic Cell Death in Brain Neurons
Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043 · cited 1×
“Overactivation of N-methyl-D-aspartate receptors caused by enhanced neural activation results in production of proinflammatory cytokines, reactive oxygen species, and nitrogen species that cause inflammation (23).”
BackgroundDevelopment of a fatigue scale
Chalder, T., Berelowitz, G., Pawlikowska, T., Watts, L., Wessely, S., Wright, D., & Wallace, E. P. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90081-p · Cited by 3,032 · cited 1×
“The Chalder fatigue scale (15) consists of 11 questions rated on a 4-point Likert scale.”
MethodAn overlap invariant entropy measure of 3D medical image alignment
Studholme, C., Hill, D. L. G., & Hawkes, D. J. (1999) · Pattern Recognition · doi:10.1016/s0031-3203(98)00091-0 · Cited by 2,180
Distribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Fatigue in neurological disorders
Chaudhuri, A., & Behan, P. O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15794-2 · Cited by 1,297
Validity and reliability of a scale to assess fatigue
Lee, K. A., Hicks, G., & Nino-Murcia, G. (1991) · Psychiatry Research · doi:10.1016/0165-1781(91)90027-m · Cited by 1,261
Myalgic encephalomyelitis: International Consensus Criteria
Carruthers, B. M., van de Sande, M. I., De Meirleir, K. L., Klimas, N. G., Broderick, G., Mitchell, T., Staines, D., Powles, A. C. P., Speight, N., Vallings, R., et al. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02428.x · Cited by 1,235
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 3×
“Previous studies have discussed the lateralization of 11C-(R)-PK11195 BPND that might have resulted from selection bias assessment of predominantly right-handed subjects (26,27).”
BackgroundMethodResultVan der Werf, Y. D., Witter, M. P., & Groenewegen, H. J. (2002) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00181-9 · Cited by 994
Brain inflammation and adult neurogenesis: The dual role of microglia
Ekdahl, C. T., Kokaia, Z., & Lindvall, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.06.052 · Cited by 801
Owen, D. R., Yeo, A. J., Gunn, R. N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D. J., Bennacef, I., Parker, C. A., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.147 · Cited by 779
Chronic Fatigue Syndrome: A Review
Afari, N., & Buchwald, D. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.221 · Cited by 687
[Chronic fatigue syndrome: a review].
Carlo-Stella, N., Lorusso, L., Candura, S. M., & Cuccia, M. (2004) · PubMed · Cited by 551
Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair
Chen, M.-K., & Guilarte, T. R. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.12.004 · Cited by 506
Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction
Pavese, N., Metta, V., Bose, S. K., Chaudhuri, K. R., & Brooks, D. J. (2010) · Brain · doi:10.1093/brain/awq268 · Cited by 333
F 2 -Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications
Basu, S. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1956 · Cited by 268
Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome
Okada, T., Tanaka, M., Kuratsune, H., Watanabe, Y., & Sadato, N. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-14 · Cited by 214
Self-citationBriard, E., Zoghbi, S. S., Imaizumi, M., Gourley, J. P., Shetty, H. U., Hong, J., Cropley, V., Fujita, M., Innis, R. B., & Pike, V. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0707370 · Cited by 193
Farooq, R. K., Isingrini, E., Tanti, A., Le Guisquet, A.-M., Arlicot, N., Minier, F., Leman, S., Chalon, S., Belzung, C., & Camus, V. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.020 · Cited by 178
Yokokura, M., Mori, N., Yagi, S., Yoshikawa, E., Kikuchi, M., Yoshihara, Y., Wakuda, T., Sugihara, G., Takebayashi, K., Suda, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1612-0 · Cited by 174
Neural correlates of the chronic fatigue syndrome--an fMRI study
de Lange, F. P., Kalkman, J. S., Bleijenberg, G., Hagoort, P., van der Werf, S. P., van der Meer, J. W. M., & Toni, I. (2004) · Brain · doi:10.1093/brain/awh225 · Cited by 170
Reduction of serotonin transporters of patients with chronic fatigue syndrome
Yamamoto, S., Ouchi, Y., Onoe, H., Yoshikawa, E., Tsukada, H., Takahashi, H., Iwase, M., Yamaguti, K., Kuratsune, H., & Watanabe, Y. (2004) · Neuroreport · doi:10.1097/00001756-200412030-00002 · Cited by 145
Self-citationA systematic review and critical evaluation of the immunology of chronic fatigue syndrome
Lyall, M., Peakman, M., & Wessely, S. C. (2003) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00515-9 · Cited by 127
Brain Regions Involved in Fatigue Sensation: Reduced Acetylcarnitine Uptake into the Brain
Kuratsune, H., Yamaguti, K., Lindh, G., Evengård, B., Hagberg, G. E., Matsumura, K., Iwase, M., Onoe, H., Takahashi, M., Machii, T., et al. (2002) · NeuroImage · doi:10.1006/nimg.2002.1260 · Cited by 125
Self-citationA neuro-immune model of myalgic encephalomyelitis/chronic fatigue syndrome
Morris, G., & Maes, M. (2013) · Metabolic Brain Disease · doi:10.1007/s11011-012-9324-8 · Cited by 117
Spinal Fluid Abnormalities in Patients with Chronic Fatigue Syndrome
Natelson, B. H., Weaver, S., Tseng, C., & Ottenweller, J. E. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.1.52-55.2005 · Cited by 115
Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome
Pall, M. L. (2000) · Medical Hypotheses · doi:10.1054/mehy.1998.0825 · Cited by 114
Evidence for the Presence of Immune Dysfunction in Chronic Fatigue Syndrome
Natelson, B. H., Haghighi, M. H., & Ponzio, N. M. (2002) · Clinical and Vaccine Immunology · doi:10.1128/cdli.9.4.747-752.2002 · Cited by 101
Shukuri, M., Takashima‐Hirano, M., Tokuda, K., Takashima, T., Matsumura, K., Inoue, O., Doi, H., Suzuki, M., Watanabe, Y., & Onoe, H. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.084046 · Cited by 93
Self-citationVas, Á., Shchukin, Y., Karrenbauer, V. D., Cselényi, Z., Kostulas, K., Hillert, J. A., Savić, I., Takano, A., Halldin, C., & Gulyás, B. Z. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.07.018 · Cited by 71
Kropholler, M. A., Boellaard, R., van Berckel, B. N. M., Schuitemaker, A., Kloet, R. W., Lubberink, M., Jonker, C., Scheltens, P., & Lammertsma, A. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600488 · Cited by 67
Psychiatric Aspects of Chronic Fatigue Syndrome and Fibromyalgia
Houdenhove, B. V., Kempke, S., & Luyten, P. (2010) · Current Psychiatry Reports · doi:10.1007/s11920-010-0105-y · Cited by 60
Harte, S. E., Spuz, C. A., & Borszcz, G. S. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.055 · Cited by 35
Unconscious amygdalar fear conditioning in a subset of chronic fatigue syndrome patients
Gupta, A. K. (2002) · Medical Hypotheses · doi:10.1016/s0306-9877(02)00321-3 · Cited by 30
Cited by
Proal, A. D., & VanElzakker, M. B. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.698169 · Cited by 876
Lim, E.-J., Ahn, Y.-C., Jang, E.-S., Lee, S.-W., Lee, S.-H., & Son, C.-G. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02269-0 · Cited by 481
Cytokine signature associated with disease severity in chronic fatigue syndrome patients
Montoya, J. G., Holmes, T. H., Anderson, J. N., Maecker, H. T., Rosenberg-Hasson, Y., Valencia, I. J., Chu, L., Younger, J. W., Tato, C. M., & Davis, M. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710519114 · Cited by 402
Komaroff, A. L., & Lipkin, W. I. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1187163 · Cited by 317
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Cortes Rivera, M., Mastronardi, C., Silva-Aldana, C., Arcos-Burgos, M., & Lidbury, B. (2019) · Diagnostics · doi:10.3390/diagnostics9030091 · Cited by 313
Metadata
- Authors
- Nakatomi, Y., Mizuno, K., Ishii, A., Wada, Y., Tanaka, M., Tazawa, S., Onoe, K., Fukuda, S., Kawabe, J., Takahashi, K., Kataoka, Y., Shiomi, S., Yamaguti, K., Inaba, M., Kuratsune, H., & Watanabe, Y.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2014-03-24
- Volume
- 55
- Issue
- 6
- Pages
- 945-950
- ISSN
- 0161-5505 (ISSN-L)
- 2159-662X
- OpenAlex
- W2115352750
- Cited by
- 365
- References
- 38
- FWCI
- 15.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.